← Back to Search

Insulin

Optimized Glucommander (OGM) for Coronary Artery Bypass Surgery

N/A
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours of post-operative hospital stay
Awards & highlights

Study Summary

The primary objective of this study is to assess the performance of an in silico designed alternative protocol for control of stress hyperglycemia of inpatients treated for Coronary Artery Bypass Graft (CABG) or valve replacement surgery in the University of Virginia cardiothoracic ICU.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours of post-operative hospital stay
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours of post-operative hospital stay for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Exposure to risk of hypoglycemia

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Optimized Glucommander (OGM)Experimental Treatment1 Intervention
CABG or open valve surgery patients treated for stress hyperglycemia with in silico optimized Glucomander protocol
Group II: Standard Glucommander Protocol (SGP)Active Control1 Intervention
CABG or open valve surgery patients treated for stress hyperglycemia with the standard Glucomander protocol according to the manufacturer recommendations

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
754 Previous Clinical Trials
1,245,038 Total Patients Enrolled
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
89 Previous Clinical Trials
19,716 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Trial to Investigate the in Silico Optimization of Insulin Treatments
Anthony McCall 2018. "Trial to Investigate the in Silico Optimization of Insulin Treatments". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03895138.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top